The prevalence of the epidermal growth factor receptor (EGFR) mutation in ASC has been reported to affect 15.4% to 44.0% of patients, which was calculated from a limited number of cases [18–21]. Here, EGFR is linked to Tako-tsubo cardiomyopathy.